Bruker (BRKR) Divestments (2013 - 2014)

Bruker's (BRKR) quarterly Divestments came in at $12.5 million in Q4 2014, up 3.31% on a QoQ basis from $12.1 million in Q3 2014.

Bruker (BRKR) Divestments (2013 - 2014) Analysis & Trends

Bruker (BRKR) has 2 years of Divestments data on file, last reported at $12.5 million in Q4 2014.

Quarterly Divestments changed N/A year-over-year to $12.5 million in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $25.3 million (up 4960.0% YoY) and the FY2015 annual result came in at $200000.0, down 99.21% from the prior year.
Divestments improved to $12.5 million in Q4 2014, from $12.1 million in the prior quarter.
In the past five years, Divestments ranged from a high of $12.5 million in Q4 2014 to a low of $500000.0 in Q1 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	-
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	-
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	-
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	-
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	-
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	-
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	153.43 Mn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	-
10	Bruker	9.13 Bn	9.13 Bn	416.00 Mn	-

Download Data